MPP inks deal with French pharma firm to fight malaria in low-income countries
15-09-2022
manjurul / iStockphoto.com
A collaboration between Bill Gates and Intellectual Ventures (IV), in partnership with conglomerate GE, has signed a licensing deal with US diagnostics technology company Access Bio to make and sell tools for “rapidly” identifying asymptomatic malaria.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Bill Gates, GE, malaria, patent licensing deal, Access Bio, Global Good, Intellectual Ventures, Plasmodium lactate dehydrogenase
